SB236

Louisiana SB236 mandates annual reviews of treatments for chronic and rare kidney diseases by the Louisiana Department of Health.

Louisiana SB236 requires the Louisiana Department of Health to conduct an annual review of all medications and forms of treatment for chronic and rare kidney diseases and services for enrollees with a diagnosis of chronic or rare kidney disease that are eligible for coverage under Medicaid. The purpose of the annual review is to determine if the available covered medications, treatments, and services are adequate to meet the needs of enrollees with a diagnosis of chronic or rare kidney disease.